Literature DB >> 19419868

Synthesis and P2Y receptor activity of nucleoside 5'-phosphonate derivatives.

Liesbet Cosyn1, Serge Van Calenbergh, Bhalchandra V Joshi, Hyojin Ko, Rhonda L Carter, T Kendall Harden, Kenneth A Jacobson.   

Abstract

Ribose-based nucleoside 5'-diphosphates and triphosphates and related nucleotides were compared in their potency at the P2Y receptors with the corresponding nucleoside 5'-phosphonate derivatives. Phosphonate derivatives of UTP and ATP activated the P2Y(2) receptor but were inactive or weakly active at P2Y(4) receptor. Uridine 5'-(diphospho)phosphonate was approximately as potent at the P2Y(2) receptor as at the UDP-activated P2Y(6) receptor. These results suggest that removal of the 5'-oxygen atom from nucleotide agonist derivatives reduces but does not prevent interaction with the P2Y(2) receptor. Uridine 5'-(phospho)phosphonate as well as the 5'-methylenephosphonate equivalent of UMP were inactive at the P2Y(4) receptor and exhibited maximal effects at the P2Y(2) receptor that were 50% of that of UTP suggesting novel action of these analogues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19419868      PMCID: PMC2721324          DOI: 10.1016/j.bmcl.2009.04.027

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  19 in total

1.  Synthesis of phosphonate derivatives of uridine, cytidine, and cytosine arabinoside.

Authors:  K Y Jung; R J Hohl; A J Wiemer; D F Wiemer
Journal:  Bioorg Med Chem       Date:  2000-10       Impact factor: 3.641

2.  Structure-activity relationships of uridine 5'-diphosphate analogues at the human P2Y6 receptor.

Authors:  Pedro Besada; Dae Hong Shin; Stefano Costanzi; Hyojin Ko; Christophe Mathé; Julien Gagneron; Gilles Gosselin; Savitri Maddileti; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2006-09-07       Impact factor: 7.446

Review 3.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

4.  Human P2Y(6) receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preference.

Authors:  Stefano Costanzi; Bhalchandra V Joshi; Savitri Maddileti; Liaman Mamedova; Maria J Gonzalez-Moa; Victor E Marquez; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2005-12-29       Impact factor: 7.446

5.  Defining the nucleotide binding sites of P2Y receptors using rhodopsin-based homology modeling.

Authors:  Andrei A Ivanov; Stefano Costanzi; Kenneth A Jacobson
Journal:  J Comput Aided Mol Des       Date:  2006-10-03       Impact factor: 3.686

6.  Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor.

Authors:  R A Nicholas; W C Watt; E R Lazarowski; Q Li; K Harden
Journal:  Mol Pharmacol       Date:  1996-08       Impact factor: 4.436

7.  Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.

Authors:  Ali El-Tayeb; Aidong Qi; Christa E Müller
Journal:  J Med Chem       Date:  2006-11-30       Impact factor: 7.446

Review 8.  Diquafosol tetrasodium: a novel dry eye therapy.

Authors:  Kelly K Nichols; Ben Yerxa; Donald J Kellerman
Journal:  Expert Opin Investig Drugs       Date:  2004-01       Impact factor: 6.206

9.  Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.

Authors:  Hyojin Ko; Rhonda L Carter; Liesbet Cosyn; Riccardo Petrelli; Sonia de Castro; Pedro Besada; Yixing Zhou; Loredana Cappellacci; Palmarisa Franchetti; Mario Grifantini; Serge Van Calenbergh; T Kendall Harden; Kenneth A Jacobson
Journal:  Bioorg Med Chem       Date:  2008-05-09       Impact factor: 3.641

10.  UDP is a competitive antagonist at the human P2Y14 receptor.

Authors:  Ingrid P Fricks; Savitri Maddileti; Rhonda L Carter; Eduardo R Lazarowski; Robert A Nicholas; Kenneth A Jacobson; T Kendall Harden
Journal:  J Pharmacol Exp Ther       Date:  2008-02-05       Impact factor: 4.030

View more
  7 in total

Review 1.  Nucleotides Acting at P2Y Receptors: Connecting Structure and Function.

Authors:  Kenneth A Jacobson; Silvia Paoletta; Vsevolod Katritch; Beili Wu; Zhan-Guo Gao; Qiang Zhao; Raymond C Stevens; Evgeny Kiselev
Journal:  Mol Pharmacol       Date:  2015-04-02       Impact factor: 4.436

2.  Synthesis and P2Y₂ receptor agonist activities of uridine 5'-phosphonate analogues.

Authors:  Sara Van Poecke; Matthew O Barrett; T Santhosh Kumar; Davy Sinnaeve; José C Martins; Kenneth A Jacobson; T Kendall Harden; Serge Van Calenbergh
Journal:  Bioorg Med Chem       Date:  2012-02-15       Impact factor: 3.641

Review 3.  Allosteric modulation of purine and pyrimidine receptors.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao; Anikó Göblyös; Adriaan P Ijzerman
Journal:  Adv Pharmacol       Date:  2011

4.  Structure-activity relationship of (N)-Methanocarba phosphonate analogues of 5'-AMP as cardioprotective agents acting through a cardiac P2X receptor.

Authors:  T Santhosh Kumar; Si-Yuan Zhou; Bhalchandra V Joshi; Ramachandran Balasubramanian; Tiehong Yang; Bruce T Liang; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

5.  Synthesis of 5'-methylene-phosphonate furanonucleoside prodrugs: application to D-2'-deoxy-2'-α-fluoro-2'-β-C-methyl nucleosides.

Authors:  Ugo Pradere; Franck Amblard; Steven J Coats; Raymond F Schinazi
Journal:  Org Lett       Date:  2012-08-23       Impact factor: 6.005

6.  Molecular recognition in the P2Y(14) receptor: Probing the structurally permissive terminal sugar moiety of uridine-5'-diphosphoglucose.

Authors:  Hyojin Ko; Arijit Das; Rhonda L Carter; Ingrid P Fricks; Yixing Zhou; Andrei A Ivanov; Artem Melman; Bhalchandra V Joshi; Pavol Kovác; Jan Hajduch; Kenneth L Kirk; T Kendall Harden; Kenneth A Jacobson
Journal:  Bioorg Med Chem       Date:  2009-05-15       Impact factor: 3.641

Review 7.  Overview of Biologically Active Nucleoside Phosphonates.

Authors:  Elisabetta Groaz; Steven De Jonghe
Journal:  Front Chem       Date:  2021-01-08       Impact factor: 5.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.